New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Research discovers master regulator of the dark genome greatly improves cancer T-cell therapy

Research discovers master regulator of the dark genome greatly improves cancer T-cell therapy

byDuke UniversityCredit: CC0 Public DomainResearchers at Duke University have adapted CRISPR technologies for high-throughput screening of gene function in human immune cells and discovered that
World medicine November 30,2023
Research discovers master regulator of the dark genome greatly improves cancer T-cell therapy

Research discovers master regulator of the dark genome greatly improves cancer T-cell therapy

byDuke UniversityCredit: CC0 Public DomainResearchers at Duke University have adapted CRISPR technologies for high-throughput screening of gene function in human immune cells and discovered that
World medicine November 30,2023
New drug shows potential in treatment of cutaneous squamous cell carcinoma

New drug shows potential in treatment of cutaneous squamous cell carcinoma

byUniversity of TurkuThe red dots in the picture are dyed cancer cells. The bottom row treated with Plixorafenib (PLX8394) shows that the drug significantly inhibits the invasion of cancer cells
World medicine November 30,2023
New drug shows potential in treatment of cutaneous squamous cell carcinoma

New drug shows potential in treatment of cutaneous squamous cell carcinoma

byUniversity of TurkuThe red dots in the picture are dyed cancer cells. The bottom row treated with Plixorafenib (PLX8394) shows that the drug significantly inhibits the invasion of cancer cells
World medicine November 30,2023
Prostate-specific antigen failure risk factors in nonmetastatic unfavorable-risk prostate cancer

Prostate-specific antigen failure risk factors in nonmetastatic unfavorable-risk prostate cancer

by Justin Jackson , Medical XpressCumulative Incidence Curves of PSA Failure by Risk Categories. High risk category is defined as age younger than 70 years, PSA 10 ng/mL or more, and a Gleason score o
World medicine November 30,2023
Prostate-specific antigen failure risk factors in nonmetastatic unfavorable-risk prostate cancer

Prostate-specific antigen failure risk factors in nonmetastatic unfavorable-risk prostate cancer

by Justin Jackson , Medical XpressCumulative Incidence Curves of PSA Failure by Risk Categories. High risk category is defined as age younger than 70 years, PSA 10 ng/mL or more, and a Gleason score o
World medicine November 30,2023
Creating a 'robust' early-detection method for pancreatic cancer

Creating a 'robust' early-detection method for pancreatic cancer

byThe Translational Genomics Research InstituteGraphical abstract. Credit:Gastroenterology(2023). DOI: 10.1053/j.gastro.2023.09.050In a significant breakthrough that could eventually
World medicine November 30,2023
Creating a 'robust' early-detection method for pancreatic cancer

Creating a 'robust' early-detection method for pancreatic cancer

byThe Translational Genomics Research InstituteGraphical abstract. Credit:Gastroenterology(2023). DOI: 10.1053/j.gastro.2023.09.050In a significant breakthrough that could eventually
World medicine November 30,2023
Research finds cancer clinical trials have become more diverse over past two decades

Research finds cancer clinical trials have become more diverse over past two decades

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainCompared to the year 2000, a greater proportion of NCI-sponsored early-phase clinical trial participants in 2022 were o
World medicine November 30,2023
Research finds cancer clinical trials have become more diverse over past two decades

Research finds cancer clinical trials have become more diverse over past two decades

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainCompared to the year 2000, a greater proportion of NCI-sponsored early-phase clinical trial participants in 2022 were o
World medicine November 30,2023
Pancreatic cancer discovery opens the door for new clinical trial

Pancreatic cancer discovery opens the door for new clinical trial

byUniversity of Rochester Medical CenterGraphical abstract. Credit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.113369Pancreatic cancer is tricky to manage because it spreads easil
World medicine November 30,2023
Pancreatic cancer discovery opens the door for new clinical trial

Pancreatic cancer discovery opens the door for new clinical trial

byUniversity of Rochester Medical CenterGraphical abstract. Credit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.113369Pancreatic cancer is tricky to manage because it spreads easil
World medicine November 30,2023
Study shows skin cancer diagnoses using AI are as reliable as those made by medical experts

Study shows skin cancer diagnoses using AI are as reliable as those made by medical experts

byMedical University of ViennaPrimary diagnostic trial aim. Credit:The Lancet Digital Health(2023). DOI: 10.1016/S2589-7500(23)00130-9Artificial intelligence (AI) is already widely u
World medicine November 30,2023
Study shows skin cancer diagnoses using AI are as reliable as those made by medical experts

Study shows skin cancer diagnoses using AI are as reliable as those made by medical experts

byMedical University of ViennaPrimary diagnostic trial aim. Credit:The Lancet Digital Health(2023). DOI: 10.1016/S2589-7500(23)00130-9Artificial intelligence (AI) is already widely u
World medicine November 30,2023
A treatment for osteoporosis and bone cancer, employed for the first time in dental filling procedures

A treatment for osteoporosis and bone cancer, employed for the first time in dental filling procedures

byAsociacion RUVIDSalvatore SauroJournal of Dental Researchpublishes a paper directed by Salvatore Sauro, Professor at University CEU Cardenal Herrera in Spain, in collaboration with inter
World medicine November 30,2023
A treatment for osteoporosis and bone cancer, employed for the first time in dental filling procedures

A treatment for osteoporosis and bone cancer, employed for the first time in dental filling procedures

byAsociacion RUVIDSalvatore SauroJournal of Dental Researchpublishes a paper directed by Salvatore Sauro, Professor at University CEU Cardenal Herrera in Spain, in collaboration with inter
World medicine November 30,2023
Researchers crack genetic code of rare kidney cancer

Researchers crack genetic code of rare kidney cancer

byWellcome Trust Sanger InstituteCredit: CC0 Public DomainThe genetic code of a rare form of kidney cancer, called reninoma, has been studied for the first time. In a paper, published inNa
World medicine November 30,2023
Researchers crack genetic code of rare kidney cancer

Researchers crack genetic code of rare kidney cancer

byWellcome Trust Sanger InstituteCredit: CC0 Public DomainThe genetic code of a rare form of kidney cancer, called reninoma, has been studied for the first time. In a paper, published inNa
World medicine November 30,2023
Veratramine found to inhibit androgen-independent prostate cancer

Veratramine found to inhibit androgen-independent prostate cancer

by Daegu Gyeongbuk Institute of Science and Technology (DGIST)Credit: Daegu Gyeongbuk Institute of Science and Technology (DGIST)The DGIST Core Protein Resources Center and Honam National Institute of
World medicine November 30,2023
Veratramine found to inhibit androgen-independent prostate cancer

Veratramine found to inhibit androgen-independent prostate cancer

by Daegu Gyeongbuk Institute of Science and Technology (DGIST)Credit: Daegu Gyeongbuk Institute of Science and Technology (DGIST)The DGIST Core Protein Resources Center and Honam National Institute of
World medicine November 30,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com